Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 9Withdrawn 2Terminated 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Lymphoid 2

Conditions

Breast Neoplasms 14Lymphoma 10Lymphoma, Large B-Cell, Diffuse 8Triple Negative Breast Neoplasms 6Lymphoma, Follicular 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Carcinoma, Hepatocellular 3Waldenstrom Macroglobulinemia 2Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Immunoblastic Lymphadenopathy 2Enteropathy-Associated T-Cell Lymphoma 2Dendritic Cell Sarcoma, Interdigitating 2Burkitt Lymphoma 2Vomiting 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Sezary Syndrome 1Rhabdomyosarcoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Platinum-Refractory Fallopian Tube Carcinoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Cyclophosphamide 3Vincristine 2Rituximab 2Prednisone 2Etoposide 2Doxorubicin 2pevonedistat 1iratumumab 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Pentetic Acid 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Minocycline 1Mannose-Binding Lectin 1Heparin 1Filgrastim 1EPOCH protocol 1Drug Therapy 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Dendritic Cell Sarcoma, Interdigitating × Doxorubicin × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

NCT00983944 2017-11-30

Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma

Ohio State University Comprehensive Cancer Center

Phase 2 Withdrawn
LymphoidSarcoma

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡